Muscular Dystrophy Dystroglycanopathy Type B6 C1837229
A group of muscle disorders caused by faulty glycosylation of a muscle protein, leading to progressive muscle weakness and wasting. It typically appears in childhood and primarily affects skeletal muscles. Treatment involves supportive care, physical therapy, and monitoring for complications.
Key facts at a glance
- ICD-10
- Q79.9
- ICD-11
- LA00.0
- Body system
- musculoskeletal
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Progressive muscle weakness
Respiratory insufficiency
Joint pain or stiffness
(musculoskeletal)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Delayed motor milestones
(musculoskeletal)Muscle atrophy
(musculoskeletal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Aggressive Physical Therapy Program
High-frequency physical therapy sessions focusing on muscle strengthening within safe limits, joint flexibility preservation, and functional independence maintenance through customized exercise protocols.
Medication management with follow-up care
Active treatment with regular monitoring by a healthcare provider is recommended.
Cardiac Pharmacological Management
Early initiation and ongoing adjustment of cardiac medications including ARBs or ACE inhibitors to manage cardiomyopathy and prevent heart failure progression.
Additional treatment options
Spinal Scoliosis Management
Surgical intervention for severe scoliosis when curvature exceeds safe limits, typically involving spinal fusion to improve posture, pulmonary function, and seating comfort.
surgicalPhysical Modalities and Massage Therapy
Complementary approaches including therapeutic massage and hydrotherapy to reduce muscle stiffness, improve circulation, and provide symptomatic relief from muscle cramps and discomfort.
complementaryComprehensive Multisystem Surveillance
Regular monitoring of cardiac, respiratory, and gastrointestinal systems with periodic laboratory assessments to detect and address complications early.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Muscular Dystrophy Dystroglycanopathy Type B6 C1837229?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Muscular Dystrophy Dystroglycanopathy Type B6 C1837229. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy